Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.
You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!
If you have any problems with the registration process or your account login, please contact contact us.
Press release: Tools to heal wounds could save millions
Monday, 14 August 2006, 1:52 pm
Press Release: Industrial Research
News release from Industrial Research Limited
14 August 2006
Using nature’s tools to heal wounds could save millions
Quote:
Natural product-based therapies for chronic wounds could take over from pharmaceutical-based treatments and artificial skin substitutes, saving the taxpayer almost a hundred million dollars per year.
Scientists at Industrial Research are working on a range of natural product wound healing therapies in collaboration with the Wellington School of Medicine and the University of Otago, and are currently focusing on grapefruit extract.
Compounds in grapefruit have been shown to promote healing through the stimulation of new blood vessels.
One of the leading causes of chronic wounds in New Zealand is diabetes.
Of the 106,000 people with Type II diabetes, 15 percent will develop a foot ulcer during the course of their disease and up to a quarter of these patients will require lower limb amputation, Industrial Research biochemist, Keryn Johnson, says.
“Wound healing is currently the ambulance at the bottom of the cliff.
“With these new natural-based therapies we hope to be the barrier at the top of the cliff – avoiding the necessity of an amputation for millions of people worldwide.”
Thirty-five percent of the cost of diabetes treatment is attributed to diabetic foot ulcers, leading to progressive amputations, Industrial Research business manager, Tom Nicolle, says.
Treatment of diabetic foot ulcers in New Zealand today is based largely on prevention. No effective therapies exist to heal these devastating wounds, which currently cost New Zealand's health care system $87 million per year, he says.
“A company that develops such a product will have access to a global market of $1.5 billion for bioactive therapies. The total number of patients with chronic wounds worldwide is a staggering 12.5 million.”
A patent on the grapefruit extract is currently being applied for in New Zealand and internationally.
Researchers hope to develop topical therapies for treating initially acute wounds, and also to identify the active components allowing development of therapies for the treatment of chronic wounds.
Moons ago when I worked in the Edinburgh School a patient came for debridment of a pressure ulcer on the plantar of his foot. After many attempts to address the gapping wound the client solved the problem by serendipidy. Accidently he stood barefoot on a "Newbury Fruit sweet '(very sweet candy with citrus flavoured liquid inside.) The chap was so convinced he had discovered the cure, he always brought a sweet for redressing. Without question his ulcer appeared to respond better than the conventional treatments had achieved. We lost contact until a colleague at the Durham School gave a clinical report of his history (The chap had moved cities and was now attending the Durham School clinic). Transpired they had experiemented with the choice of sweet from the Newberry Fruit collection and found only the lemon flavoured candy had the desired effect.
The patient was an academic and wrote up his own case history.